Our findings define a complete PATZ1/CTCF-ZBTB20-PMEPA1-p38-STAT1 oncogenic pathway and establish that the dysregulation of the PATZ1/CTCF dynamic balance via DNA-binding competition represents a novel epigenetic mechanism driving melanoma progression. The gene discussed is ZBTB20; the disease is melanoma.